权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants

开发一种改善早产儿语音分化的治疗装置

基本信息

批准号：
10697501
负责人：
Dean R Koch
金额：
$ 119.15万
依托单位：
THRIVE NEUROMEDICAL, LLC
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-05-03 至 2026-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10697501
关键词：
2 year old Active Learning Address Adult Affect Age Auditory Auditory Perception Auditory system Behavior assessment Birth Brain Calibration Caregivers Caring Child Clinical Clinical Research Clinical Trials Cognition Cognitive Complex Data Development Developmental Delay Disorders Devices Economics Electroencephalography Ensure Environment Exposure to Family Foundations Funding Geography Hearing Hospitalization Hospitals Human Impairment Incubators Infant Infection Control Intervention Justice Language Language Delays Language Development Learning Loudness Marketing Measurement Measures Mothers Neonatal Intensive Care Units Newborn Infant Noise Nurses Outcome Outcome Measure Pacifiers Parents Pattern Phase Physiological Policies Population Pregnancy Premature Birth Premature Infant Process Protocols documentation Randomized Randomized, Controlled Trials Reading Recommendation Research Safety Schedule School-Age Population Speech Speech Sound Stimulus Structure System Team Nursing Technology Testing Therapeutic Time United States Universities Uterus Voice auditory processing auditory stimulus awake brain based clinical practice cognitive development design early childhood effective intervention empowerment experience family support health determinants high risk improved improved outcome infancy infection risk innovation intervention effect language outcome language processing manufacture medically necessary care neural neural circuit neurosensory peer premature pressure product development prototype psychologic research and development response sensor social social health determinants sound standard care sucking targeted treatment verbal

项目摘要

PROJECT DESCRIPTION Thrive Neuromedical LLC proposes to develop, test, and gain FDA clearance to market a therapeutic device to improve speech sound differentiation in preterm infants hospitalized in the neonatal intensive care unit (NICU). During this project we will complete development of the smallTalk NICU Active system and conduct a clinical trial to prove its efficacy in improving speech sound differentiation among hospitalized preterm infants. The device is designed to be used at an age equivalent to 32 weeks of gestation or older and to integrate readily into clinical practice for use by nurses and therapists staffing Level II to Level IV NICUs. Prototype research and development met or exceeded the stated technical milestones. In 2020, preterm birth affected 1 of every 10 infants born in the United States. Large numbers of infants are born daily requiring NICU stays. This NICU stay, while medically necessary, can result in impairments in the developing infant brain. In particular, there is a lack of exposure to infant directed parental or caretaker voice. It is known that exposure to infant directed speech, which is different from adult directed speech, is developmentally important for optimal, early brain development. The ability to differentiate speech sounds is a prerequisite for developing more complex receptive language. Infant directed speech, ideally when sought by an attentive infant, stimulates brain wiring and attunes the infant’s brain to speech sounds. For the developing infant brain, “plasticity” for language learning peaks during infancy, as the baby develops neural connections that enable differentiating their native language’s speech sounds. These connections are the foundation for more complex brain functions. Due in part to their time in NICU care, preterm infants have poorer receptive language scores at age two. A majority require speech and language intervention prior to school age. There is currently no intervention that addresses the problem of poor speech sound differentiation arising from NICU hospitalization, a period when the greatest potential for improving outcomes exists. This proposal seeks funding for the final product development and rigorous testing of the smallTalk NICU Active system. We will manufacture a small batch of the devices to support a proposed randomized clinical study at Emory University, the results of which will be submitted to FDA for clearance to market the innovative device.

项目描述